肝癌合并肝硬化患者血小板参数的变化及影响因素

丁胜楠; 杨伟民; 牛俊奇

doi:10.3969/j.issn.1001-5256.2014.06.020

肝癌合并肝硬化患者血小板参数的变化及影响因素

DOI: 10.3969/j.issn.1001-5256.2014.06.020

吉林大学白求恩第一医院肝胆内科

详细信息

中图分类号: R575.2;R735.7
计量
- 文章访问数: 3133
- HTML全文浏览量: 11
- PDF下载量: 651
- 被引次数: 0
出版历程
- 收稿日期: 2014-04-23
- 出版日期: 2014-06-20

Changes in platelet parameters and their influential factors in cirrhotic patients with hepatocellular carcinoma

Department of Hepatobiliary and Pancreatic Diseases, The First Hospital of Jilin University

摘要

摘要:
目的分析肝癌合并肝硬化患者血小板参数的变化及影响因素。方法收集2011年1月-2012年12月吉林大学白求恩第一医院602例肝癌合并肝硬化、200例肝硬化患者的相关资料。应用SPSS19.0统计软件进行分析,计量资料符合正态分布的以均数±标准差（x±s）表示,两组之间的比较采用t检验,多组之间采用方差分析;非正态分布以中位数和四分位数间距[M（P25P75）]表示,组间分析用秩和检验。结果肝癌组的血小板（PLT）、血小板比容（PCT）值明显高于肝硬化组（t=5.019、5.017,P均=0.000）,MPV/PLT值明显低于肝硬化组（t=5.877,P=0.000）,平均血小板体积（MPV）、血小板分布宽度（PDW）差异没有统计学意义（t=-0.942,P=0.347;t=-1.040,P=0.298）。PLT、PCT、MPV/PLT诊断肝硬化后肝癌的ROC曲线下面积分别是0.636,0.633,0.639。PLT、PCT值减少与HCV感染密切相关。PLT、PCT值Child A级患者大于B级、C级（P<0.01）,肿瘤≥5 cm患者大于肿瘤≤2 cm和2<...
- 肝肿瘤 /
- 肝硬化 /
- 血小板 /
- 影响因素分析
Abstract:
Objective To analyze the changes in platelet parameters and their influential factors in cirrhotic patients with hepatocellular carcinoma ( HCC) . Methods The clinical data of 602 cirrhotic patients with HCC who were admitted to the First Hospital of Jilin University from January 2011 to December 2012, as well as 200 cirrhotic patients hospitalized during the same period, were collected. Statistical analysis was performed using SPSS 19. 0. Normally distributed continuous data were expressed as mean ± standard deviation; comparison between two groups was made by t test, and comparison between multiple groups was made by analysis of variance. Non- normally distributed data were expressed as median and interquartile range ( P25- P75) ; comparison between groups was made by rank sum test. Results Compared with the cirrhotic group, the HCC group had significantly higher platelet count ( PLT) and plateletcrit ( PCT) ( t = 5. 019, P = 0. 000;t = 5. 017, P = 0. 000) and a significantly lower mean platelet volume ( MPV) /PLT ( t = 5. 877, P = 0. 000) ; there were no significant differences in MPV and platelet distribution width between the two groups ( t =- 0. 942, P = 0. 347; t =- 1. 040, P = 0. 298) . The receiver operating characteristic ( ROC) analysis showed that the area under the ROC curve was 0. 636 for PLT, 0. 633 for PCT, and 0. 639 for MPV /PLT in the diagnosis of HCC in cirrhotic patients. Decreases in PLT and PCT were closely related to hepatitis C virus ( HCV) infection. Patients with Child- Pugh class A cirrhosis had significantly higher PLT and PCT than those with Child- Pugh class B and C cirrhosis ( P <0.01) ; patients with a maximum tumor diameter of ≥5 cm had significantly higher PLT and PCT than those with maximum tumor diameters of 2- 5 cm and ≤2 cm ( P < 0. 01) . Patients with Child- Pugh class A cirrhosis had a significantly lower MPV /PLT than those with Child- Pugh class B and C cirrhosis ( P < 0. 01) ; patients with a maximum tumor diameter of ≥5 cm had a significantly lower MPV /PLT than those with maximum tumor diameters of 2- 5 cm and ≤2 cm ( P < 0. 01) . Conclusion PLT, PCT, and MPV /PLT can be used in the auxiliary diagnosis of HCC in cirrhotic patients, which are related to HCV, Child- Pugh classification, and tumor size.
- liver neoplasms /
- liver cirrhosis /
- blood platelet /
- root cause analysis

HTML全文

参考文献(17)

[1]NOZAKI R, MURATA S, NOWATARI T, et al.Effects of thrombopoietin on growth of hepatocellular carcinoma:Is thrombopoietin therapy for liver disease safe or not?[J].Hepatol Res, 2013, 43 (6) :610-620.

[2]LATVALA J, PARKKILA S, NIEMEL O.Excess alcohol consumption is common in patients with cytopenia:studies in blood and bone marrow cells[J].Alcohol Clin Exp Res, 2004, 28 (4) :619-624.

[3]JENNE CN, URRUTIA R, KUBES P.Platelets:bridging hemostasis, inflammation, and immunity[J].Int J Lab Hematol, 2013, 35 (3) :254-261.

[4]CHEN CC, CHANG JY, LIU KJ, et al.Hepatocellular carcinoma associated with acquired von Willebrand disease and extreme thrombocytosis[J].Ann Oncol, 2005, 16 (6) :988-989.

[5]HWANG SJ, LUO JC, LI CP, et al.Thrombocytosis:a paraneoplastic syndrome in patients with hepatocellular carcinoma[J].World J Gastroenterol, 2004, 10 (17) :2472-2477.

[6]CARR BI, GUERRA V.Thrombocytosis and hepatocellular carcinoma[J].Dig Dis Sci, 2013, 58 (6) :1790-1796.

[7]BERGER FG.The interleukin-6 gene:a susceptibility factor that may contribute to racial and ethnic disparities in breast cancer mortality[J].Breast Cancer Res Treat, 2004, 88 (3) :281-285.

[8]PORTA C, DE AMICI M, QUAGLINI S, et al.Circulating interleukin-6 as a tumor marker for hepatocellular carcinoma[J].Ann Oncol, 2008, 19 (2) :353-358.

[9]GIANNITRAPANI L, CERVELLO M, SORESI M, et al.Circulating IL-6 and sIL-6R in patients with hepatocellular carcinoma[J].Ann N Y Acad Sci, 2002, 963:46-52.

[10]MALAQUARNERA M, DI FAZIO I, LAURINO A, et al.Role of interleukin 6 in hepatocellular carcinoma[J].Bull Cancer, 1996, 83 (5) :379-384.

[11]MARRERO JA, FENG Z, WANG Y, et al.Alpha-fetoprotein, desgamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma[J].Gastroenterology, 2009, 137 (1) :110-118.

[12]WANG CS, YAO WJ, WANG ST, et al.Strong association of hepatitis C virus (HCV) infection and thrombocytopenia:implications from a survey of a community with hyperendemic HCV infection[J].Clin Infect Dis, 2004, 39 (6) :790-796.

[13]GIANNINI EG, SAVARINO V.Further insights into the causes of thrombocytopenia in chronic hepatitis C[J].J Gastrointestin Liver Dis, 2010, 19 (4) :357-358.

[14]LI Q, SUN GZ, WANG BE, et al.The relationship among the counts of platelet, thrombopoietin and spleen index in patients with liver cirrhosis[J].Chin J Hepatol, 2004, 12 (4) :210-212. (in Chinese) 李琴, 孙桂珍, 王宝恩, 等.肝硬化患者血小板计数与血小板生成素及脾脏指数间的关系[J].中华肝脏病杂志, 2004, 12 (4) :210-212.

[15]CARR BI, GUERRA V, PANCOSKA P.Thrombocytopenia in relation to tumor size in patients with hepatocellular carcinoma[J].Oncology, 2012, 83 (6) :339-345.

[16]CARR BI, GUERRA V, DE GIORGIO M, et al.Small hepatocellular carcinomas and thrombocytopenia[J].Oncology, 2012, 83 (6) :331-338.

[17]CARR BI, GUERRA V.Hepatocellular carcinoma size:platelets, γ-Glutamyl transpeptidase, and alkaline phosphatase[J].Oncology, 2013, 85 (3) :153-159.

施引文献

资源附件(0)

访问统计